Search

everythinglearnresearchcommunity

for

Search:↓

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Small white dots on the scalp seen with a dermoscope correspond to sweat ducts and vary with different hair disorders.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Some women with common hair loss may develop permanent hair loss.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.